XML 23 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-Based Compensation
3 Months Ended
Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation

Note 7. Stock–Based Compensation

 

Issuance of restricted common stock – directors, officers and employees

 

During the three months ended March 31, 2018, the Company granted 750,000 shares of restricted common stock to Mr. Robert Lowrey in connection with his employment agreement to serve as the Company’s Chief Financial Officer. The Company valued the award on its grant date and is expensing the grant date fair value over the 24 month vesting period.

 

The Company’s activity in restricted common stock was as follows for the three months ended March 31, 2018:

 

    Number of shares     Weighted average
grant date fair
value
 
Non–vested at January 1, 2018     3,850,000     $ 1.42  
Granted     750,000     $ 1.97  
Vested     (1,350,000 )   $ 1.39  
Forfeited              
Non–vested at March 31, 2018     3,250,000     $ 1.56  

 

For the three months ended March 31, 2018 and 2017, in connection with the vesting of restricted common stock awards, the Company has recorded $1,087 and $338, in employee and director stock–based compensation expense, which is a component of general and administrative expense in the unaudited condensed consolidated statement of operations and comprehensive loss.

 

As of March 31, 2018, unamortized stock-based compensation costs related to restricted share arrangements was $3,892, and will be recognized over a weighted average period of 1.26 years.

 

Stock options

 

The following is a summary of the Company’s stock option activity for the three months ended March 31, 2018:

 

    Options     Weighted
average
exercise price
    Weighted
average Grant date fair value
    Weighted average remaining
life
    Intrinsic value  
Outstanding – January 1, 2018     6,000,000     $ 0.71     $ 1.29                  
Granted                                      
Exercised                                      
Forfeited/Cancelled                                      
Outstanding – March 31, 2018     6,000,000     $ 0.71     $ 1.29       4.38     $ 3,460  
                                         
Exercisable – March 31, 2018     6,000,000     $ 0.71     $ 1.29       4.38     $ 3,460  

 

For the three months ended March 31, 2018 and 2017, the Company has recorded $0 and $962, respectively, in stock option related stock-based compensation expense, which is a component of general and administrative expense in the unaudited condensed consolidated statement of operations and comprehensive loss.

 

As of March 31, 2018, there were no unrecognized compensation costs, as all outstanding stock options are fully vested.